about
Advanced gastric cancer: What we know and what we still have to learnColorectal cancer: Metastases to a single organHyperthermic Intraperitoneal Chemotherapy and Cytoreductive Surgery in the Management of Peritoneal CarcinomatosisPeritoneal tumor carcinomatosis: pharmacological targeting with hyaluronan-based bioconjugates overcomes therapeutic indications of current drugsPeripheral opioid antagonist enhances the effect of anti-tumor drug by blocking a cell growth-suppressive pathway in vivoCurrent treatment options for colon cancer peritoneal carcinomatosis.Hyperthermic intraperitoneal chemotherapy with cisplatin and paclitaxel in advanced ovarian cancer: a multicenter prospective observational studyPharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer.Laparoscopic Confocal Laser Microscopy Without Fluorescent Injection: A Pilot Ex Vivo Study in Colon Cancer.MicroRNA-106a functions as an oncogene in human gastric cancer and contributes to proliferation and metastasis in vitro and in vivo.Self-Expandable Metallic Stent Placement in Malignant Gastric Outlet Obstruction: A Comparison Between 2 Brands of StentsEstablishment of a novel method to evaluate peritoneal microdissemination and therapeutic effect using luciferase assay.Regional CAR-T cell infusions for peritoneal carcinomatosis are superior to systemic deliveryPrecise integrin-targeting near-infrared imaging-guided surgical method increases surgical qualification of peritoneal carcinomatosis from gastric cancer in mice.Intraperitoneal immunotherapy with T cells stably and transiently expressing anti-EpCAM CAR in xenograft models of peritoneal carcinomatosisTargeting of p32 in peritoneal carcinomatosis with intraperitoneal linTT1 peptide-guided pro-apoptotic nanoparticles.The current status of immunotherapy in peritoneal carcinomatosis.Nanoparticle drug-delivery systems for peritoneal cancers: a case study of the design, characterization and development of the expansile nanoparticle.Cytoreductive surgery combined with hyperthermic intraperitoneal chemoperfusion for the treatment of gastric cancer: A single-centre retrospective study.Regional hyperthermia of the abdomen, a pilot study towards the treatment of peritoneal carcinomatosis.Improved Debulking of Peritoneal Tumor Implants by Near-Infrared Fluorescent Nanobody Image Guidance in an Experimental Mouse Model.Ra-224 Labeling of Calcium Carbonate Microparticles for Internal α-Therapy: Preparation, Stability and Biodistribution in Mice.High Penetration of Paclitaxel in Abdominal Wall of Rabbits after Hyperthermic Intraperitoneal Administration of Nab-Paclitaxel Compared to Standard Paclitaxel Formulation.The peritoneal "soil" for a cancerous "seed": a comprehensive review of the pathogenesis of intraperitoneal cancer metastases.Anti-neoplastic drugs increase caveolin-1-dependent migration, invasion and metastasis of cancer cells.Single-incision flexible endoscopy (SIFE) for detection and staging of peritoneal carcinomatosis.CT differentiation of diffuse malignant peritoneal mesothelioma and peritoneal carcinomatosis.Increased Plasma Levels of Danger-Associated Molecular Patterns Are Associated With Immune Suppression and Postoperative Infections in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ovarian and gastrointestinal peritoneal carcinomatosis: results from a 7-year experience.Prospective, single-center implementation and response evaluation of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis.Clinical significance of heat shock proteins in gastric cancer following hyperthermia stress: Indications for hyperthermic intraperitoneal chemoperfusion therapy.
P2860
Q26774528-87181C65-0E48-4516-8A12-AEE6D95DBE77Q26778009-7A1355BC-1AE5-4BCA-9E5C-4AB06BF2DAA9Q28077394-C72E459A-6870-44B4-8A3A-FD9BEE992569Q28544821-1BEFE780-C5AD-45B6-9F98-770A832E9887Q28545949-FB40E47B-10A8-473B-85BF-C594F2B4BAC4Q34207816-D6069E49-0766-40E6-9DD9-8D87D0AC4BBCQ34996992-257CA943-AF38-4F1D-A5AE-708D61F1AD81Q35476298-41D9F049-08C7-475B-BA99-4E7D086A0EA4Q35956976-EFB7602F-633A-4CB1-9618-81910E1A1349Q36008004-2C6BB1BB-2763-4348-BD72-B1F1A3299F9BQ36153493-CA0CA8E5-F54A-4B62-9EAA-25A8396BA10DQ36746267-C9449389-CA37-45A7-9026-D85E05474870Q37497357-A01C10CB-2501-428B-B5EE-77ACC8689B51Q37701587-6527C530-3907-4FD7-B8CD-D639EFD3593BQ37706662-C09F2D12-60A1-43AE-B6DC-09629B48B6DDQ38731251-B8C6A092-0B02-428C-AE77-B3B8267C2B49Q38830852-5A87802D-17C2-49F5-9541-B6908566ADA9Q39129504-8EB46609-3EFC-4066-990D-80FA62D5BD93Q39642640-3F932936-CEF8-42E8-8B1F-7B79C5559E42Q41772742-DA63E4F4-7B02-4A49-9FB2-D5A45F9B8B96Q48091253-FB56C6BB-6571-4821-9DDE-E521CD4865D8Q48144362-320230BC-C031-4209-813A-5603778AD600Q48182234-FE3E192D-D8D8-4F1D-9F01-6756761D6097Q48278671-74041257-774C-4D53-96AC-251D88DAC223Q49230399-DDA61B77-FD7A-43CE-82F1-679F9AB14D79Q51609373-AA34E3BD-6CBF-4897-8358-5F158FBC4DB0Q52987178-64CE6B00-146E-4AEC-9667-54475A760FA0Q55044603-4C1B7E6C-E507-4B2A-B544-6CA7DEBDA224Q55258604-66AFE455-FA76-4B19-ADC3-0F19261D4F7FQ55376619-4F6A93A7-1129-44F2-A03C-00F03A819316Q55396753-93A77B29-14D2-41EE-AE4B-0F74852F82B3
P2860
description
im November 2013 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 November 2013
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2013
@uk
name
Peritoneal carcinomatosis
@en
Peritoneal carcinomatosis
@nl
type
label
Peritoneal carcinomatosis
@en
Peritoneal carcinomatosis
@nl
prefLabel
Peritoneal carcinomatosis
@en
Peritoneal carcinomatosis
@nl
P2093
P2860
P50
P356
P1476
Peritoneal carcinomatosis
@en
P2093
Claudio Ghermandi
Domenico Iusco
Fausto Catena
Federico Coccolini
Federico Gheza
Marco Lotti
Salvatore Virzì
Stefano Maria Giulini
P2860
P304
P356
10.3748/WJG.V19.I41.6979
P407
P577
2013-11-01T00:00:00Z